Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees.  Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).

Eli Lilly & Co. terlibat dalam penemuan, pengembangan, pembuatan, dan penjualan produk farmasi. Perusahaan ini berkantor pusat di Indianapolis, Indiana dan saat ini mempekerjakan 47.000 karyawan penuh waktu. Produk kesehatan kardiometaboliknya meliputi Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, dan lainnya; Humulin, Humulin 70/30, dan lainnya; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, dan VERVE-301. Produk onkologi-nya termasuk Cyramza, Erbitux, Tyvyt, dan Verzenio. Produk imunologinya meliputi Ebglyss, Olumiant, Omvoh, dan Taltz. Produk neuro ilmiah-nya termasuk Emgality dan Kisunla. Perusahaan ini, melalui anak perusahaannya, POINT Biopharma Global Inc., terlibat dalam penemuan, pengembangan, dan upaya pembuatan radiopharmaceutical, serta terapi radioligand klinis dan pra-klinis yang sedang dikembangkan untuk pengobatan kanker. Perusahaan ini juga sedang mengembangkan penghambat molekul kecil oral a4b7 integrin untuk penyakit radang usus (IBD).

Eli Lilly

NVIDIA

Apple

Microsoft

Google

Amazon

Broadcom

Meta Platforms

Taiwan Semiconductor

Tesla

Berkshire Hathaway

JPMorgan

Walmart

Visa

Oracle

MasterCard

Exxon Mobil

Netflix

Johnson & Johnson

Palantir

SPDR S&P500 ETF

AbbVie

Costco

ASML

Bank of America

Alibaba

Home Depot

Procter & Gamble

General Electric

UnitedHealth Group

Chevron

Coca-Cola

Vanguard Total Stock Market ETF

Cisco

AstraZeneca

Micron Technology

Wells Fargo

Toyota

Morgan Stanley

Caterpillar

American Express

Novartis

Philip Morris

Goldman Sachs

Raytheon Technologies

T-Mobile

Salesforce

Merck

Abbott

Shell

McDonald's

Novo Nordisk

Royal Bank of Canada

Disney

Shopify

Intuitive Surgical

Lam Research

Invesco QQQ Trust

Linde PLC

PepsiCo

Uber

QUALCOMM

Citigroup

Intuit

Applied Materials

AT&T

Sony

Amgen

ServiceNow

NextEra Energy

Blackstone

Charles Schwab

Verizon

Intel

Arista Networks

BlackRock

Booking Holdings

Banco Santander

Danaher

Boston Scientific

Accenture

Gilead Sciences

S&P Global

Unilever

Boeing

Texas Instruments

Pfizer

Capital One

Adobe

Palo Alto Networks

Toronto-Dominion Bank

TotalEnergies

CrowdStrike

Spotify

Saham Eli Lilly

Tentang Eli Lilly

Statistik Kunci